Health
YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection
GAITHERSBURG, Md., Sept. 15, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious dise...
2023-09-15 20:30
2328
Prenetics Announces Second Quarter 2023 Financial Results
HONG KONG, Sept. 15, 2023 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, today announced financial results for the second quarter endedJune 30, 2023, along with recent business updates. Second Quarter 2023...
2023-09-15 19:10
5898
MGI Introduces New Chapter in Smart Laboratory Management with Official Opening of αLab in HKSTP
HONG KONG, Sept. 15, 2023 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science, today announced the official opening of αLab in the Hong Kong Science & Technology Parks ("HKSTP"), the city's largest R&D base and one of the most important incubators. ...
2023-09-15 18:35
2449
Neoss® Group has launched a new wireless intraoral scanner, NeoScan™ 2000
ZURICH, Sept. 15, 2023 /PRNewswire/ -- Neoss Group, a leading innovator in
dental implant solutions, is proud to announce the fast and easy-to-use
wireless intraoral scanner, NeoScan™ 2000. This follows the success of last
year's launch of the NeoScan™ 1000.
2023-09-15 16:00
1978
Green Leadership Award Presented to Chugai Pharma Taiwan at the Asia Responsible Enterprise Awards 2023
SINGAPORE, Sept. 14, 2023 /PRNewswire/ -- The Asia Responsible Enterprise Awards (AREA) 2023 is pleased to honor 30 outstanding business leaders and enterprises for championing sustainable and responsible business practices. Presented by leading regional NGO Enterprise Asia, the AREA is the mo...
2023-09-15 11:37
1850
MGI Partners with National Cancer Centre Singapore to Undergo Comprehensive Genomic Profiling of Asian-Prevalent Cancers
SINGAPORE, Sept. 15, 2023 /PRNewswire/ -- MGI Tech Singapore Pte, Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, recently entered a research partnership with National Cancer Centre Singapore ("NCCS") to facilitate comprehensive, multi-dimensional gen...
2023-09-15 11:00
2622
MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study
GENEVA, Sept. 15, 2023 /PRNewswire/ -- MedAlliance has announced enrollment of over 1,660 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now half way towards a planned 3,326 patients. SELUTION DeNovo compares the treatment strategy using a novel sirolimu...
2023-09-15 08:00
2075
Variants in the genome interact with each other and with the environment to affect risk of cardiovascular disease
REYKJAVIK, Iceland, Sept. 14, 2023 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare system and TheCopenhagen University, publish a study today in the journal Cell titled "Complex effects of sequence variants on lipid level...
2023-09-14 23:00
2303
Foundry Mixer Healthcare, Indonesian Minister of Health Budi G. Sadikin: "Together We Leapfrog Indonesia's Healthcare Transformation"
Indonesian Minister of Health, Budi Gunadi Sadikin, emphasized that investing in the Health Technology and Biotechnology sector serves not only business prospects but also strengthens Indonesia's health resilience and adds value to healthcare. JAKARTA, Indonesia, Sept. 14, 2023 /PRNewswire/ -- F...
2023-09-14 17:47
1683
Break the cycle of dehydration and skin sensitivity with the NEW Cetaphil® Optimal Hydration Skin Replenishing Water Gel
The NEW Cetaphil Skin Replenishing Water Gel is clinically proven to provide 72-hour hydration with its slow-release technology containing Hyaluronic Acid and Polyglutamic Acid KUALA LUMPUR, Malaysia, Sept. 14, 2023 /PRNewswire/ -- Cetaphil®, the #1 dermatological skincare brand inMalaysia intro...
2023-09-14 17:17
1899
Neoss® Group launches NeoTell™ a new device to measure implant stability.
ZÜRICH, Sept. 14, 2023 /PRNewswire/ -- Earlier this year, Neoss Group, a pioneer in dental implant solutions, announced a partnership with Osstell AB, a global leader in implant stability measurement and osseointegration progress monitoring. Today, we proudly introduce the first fruit of this col...
2023-09-14 16:00
1643
Two Affiliated Hospitals Unveiled Simultaneously, Neusoft Education Exerts Efforts In a New Ecosystem Of Healthcare Technology Education
HONG KONG, Sept. 14, 2023 /PRNewswire/ -- On the morning of September 14, the unveiling ceremony of Dalian Neusoft University of Information's affiliated Cardiovascular Hospital and affiliated Stomatological Hospital was held at the phase II square of the provincial-level university science and t...
2023-09-14 13:53
4850
Innovative Collaboration: Buzzreach and Oncoshot Spearhead Clinical Trial Advancements in Japan
SINGAPORE, Sept. 14, 2023 /PRNewswire/ -- Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration to accelerate clinical trials inJapan. The former specialises in clinical trial site recruitment and retention and project managemen...
2023-09-14 10:00
2546
MGI and Bio-Medical Science Sign MOU to Deliver Cutting-Edge Sequencing Platforms and Reagents to South Korea
CHEONAN, South Korea, 14 September 2023 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science, today announced MOU with Bio-Medical Science Co., Ltd. ("BMS") to expand genomics solutions inSouth Korea by leveraging MGI's cutting-edge technology. The M...
2023-09-14 09:00
1848
Avasa raises $1.55M in oversubscribed funding round with innovative implantable devices
MIAMI and AUCKLAND, New Zealand, Sept. 14, 2023 /PRNewswire/ -- Avasa, a medical device pioneer advancing surgical techniques for improved patient outcomes, announces the successful completion of its recent funding, raising an impressive$1.55 million in capital investment. The influx of new inves...
2023-09-14 04:50
1981
AWAK TECHNOLOGIES RAISES US$20+ MILLION, READYING ITS WEARABLE DIALYSIS DEVICE FOR US-BASED PIVOTAL TRIAL
* AWAK closes one of the largest MedTech fundraise in 2023 in Southeast Asia * The Series B round was co-led by new investor Lion X Ventures and long-term investor Vickers Venture Partners, along with other new and existing investors * AWAK's ultra-portable peritoneal dialysis system enables ...
2023-09-13 21:27
2496
Exelixis and Insilico Medicine Enter into Exclusive Global License Agreement for ISM3091, a Potentially Best-in-Class USP1 Inhibitor
— ISM3091 is a highly selective, orally bioavailable small molecule inhibitor of USP1 identified through Insilico Medicine's artificial intelligence (AI) platform, with potent activity in BRCA-mutated tumor models — — In May 2023, the U.S. Food and Drug Administration (FDA) cleared Insilico's I...
2023-09-13 20:29
1958
Global Times: Witness to history: Chinese people in Morocco share life-and-death earthquake experiences, rush to assist locals to get through disaster
BEIJING, Sept. 13, 2023 /PRNewswire/ -- At 1.28 am, obstetrician Zhang Qian finally heard the loud cry of a baby. It was a healthy baby girl. Zhang breathed a sigh of relief performing after a nerve-racking hour-long C-section on a Moroccan patient. While in surgery at a Moroccan hospital, Zhang ...
2023-09-13 19:48
1619
91% of doctors in Southeast Asia participate in digital learning despite societal return to in-person interactions - Docquity
* Docquity survey shows that doctor attendance at digital learning events is higher than in-person events (at 3.9 versus 3.0 times per month) * While two learning cohorts have emerged - digital dominant learners and in-person dominant learners, both groups participate in digital learning yet ...
2023-09-13 10:55
749
Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf® in Taiwan and select South-East Asian markets
SINGAPORE, Sept. 13, 2023 /PRNewswire/ -- Menarini Asia-Pacific has entered into a long-term exclusive licensing partnership with Astellas Pharma Inc. (Astellas) for the development, manufacturing and commercialization of the orally administered Janus kinase (JAK) inhibitor Smyraf® 50 mg and 100 ...
2023-09-13 10:30
2605
Week's Top Stories
Most Reposted
Singapore's IMAGINE AI: Largest Global Gathering to Shape the Future of Healthcare with AI Innovations
[Picked up by 316 media titles]
2024-12-06 10:41
AC Health makes critical HIV care more accessible to Filipinos with USAID support
[Picked up by 310 media titles]
2024-12-03 16:11
Building Asia's Future: Omni HR Secures $7.4mn for HR Tech Expansion
[Picked up by 304 media titles]
2024-12-09 10:00
CCTV+: Yuhang Journey ǀ Follow Olivier to Explore Ancient Liangzhu and Savor Jingshan Tea
[Picked up by 283 media titles]
2024-12-08 20:07Audit finds no irregularities in Nagad
[Picked up by 271 media titles]
2024-12-05 01:20Most Read
Singapore's IMAGINE AI: Largest Global Gathering to Shape the Future of Healthcare with AI Innovations
2024-12-06 10:41
5848
Qi Biodesign Completes $75 Million in Total Funding to Drive Genome Editing Innovations
2024-12-06 20:15
5754
BROOKLYN NETS AND PHOENIX SUNS TO PLAY TWO PRESEASON GAMES IN MACAO IN OCTOBER 2025
2024-12-06 21:09
4941
Guangzhou and Aksu Spotlight Cultural Heritage at the 2024 Understanding China Conference
2024-12-06 23:11
4550
AC Health makes critical HIV care more accessible to Filipinos with USAID support
2024-12-03 16:11
4423